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com confirmação histopatológica
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Pleomorphic xanthoastrocytoma (PXA), classically 
described as a superficial supratentorial glioma that af-
fects young patients, is associated with extensive menin-
geal involvement1. Moreover, it occurs in patients with a 
long history of epilepsy. Despite their histologic appear-
ance of cellular pleomorphism and the presence of giant 
cells, literature reviews indicate a good prognosis for this 
tumor2-7. It is a grade II tumor, according to the World 
Health Organization (WHO) classification of tumors of 
the central nervous system (CNS)8. However, PXA is as-
sociated with high rates of recurrence, anaplastic trans-
formation9-11 and death12 when comparing with other as-
trocytic tumors of good prognosis. This study aimed to 
analyze magnetic resonance imaging (MRI) characteris-
tics in a series of patients diagnosed with pleomorphic 
xanthoastrocytoma in a university hospital.
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ABSTRACT
Pleomorphic xanthoastrocytoma (PXA) is a rare glioma. This paper aimed to analyze magnetic resonance imaging (MRI) characteristics in a 
series of patients diagnosed with PXA. We analyzed MRI findings in 9 patients with histopathologic diagnosis of PXA in our department over 
the last 12 years. The mean age of patients was 27.3 years. Cortical location was observed in all cases. The lesion imaging was solid-cystic in 
six cases. In eight cases, the solid component presented hypo or isointense on T1 and iso or hyperintense on T2. Contrast enhancement in the 
solid component was observed in eight cases. The observed imaging pattern of PXA was superficial location with leptomeningeal involvement, 
solid-cystic pattern and contrast enhancement in the solid component. We should consider that the association between PXA and other corti-
cal tumors may occur, particularly, with gangliogliomas, which tend to be the main differential diagnosis in MRI.
Key words: magnetic resonance imaging, central nervous system, astrocytoma.
RESUMO
Xantoastrocitoma pleomórfico (PXA) é um glioma raro. Este estudo teve como objetivo analisar aspectos de imagem por ressonância magnética 
(RM) de uma série de pacientes com diagnóstico de PXA. Foram analisados exames de RM de 9 pacientes com diagnóstico histopatológico de PXA 
nos últimos 12 anos. A média de idade dos pacientes foi de 27,3 anos. Localização cortical foi observada em todos os casos. Padrão sólido-cístico foi 
observado em seis casos. Em oito casos, o componente sólido apresentou-se hipo ou isointenso em T1 e iso ou hiperintenso em T2. Foi observada 
captação de contraste na porção sólida em oito casos. O padrão de imagem observado do PXA foi de localização superficial com envolvimento lepto-
meníngeo, padrão sólido-cístico e captação de contraste pelo componente sólido. Devemos considerar que a associação entre PXA e outros tumores 
corticais pode ocorrer, particularmente, com ganglioglioma, que tende a ser o principal diagnóstico diferencial em RM.
Palavras-Chave: imagem por ressonância magnética, sistema nervoso central, astrocitoma.
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METHODS
Between January 1999 and December 2010, we obtained MRI 
findings of all patients with histopathologic diagnosis of PXA in 
our department. The sample comprised 9 patients (6 males and 
3 females) and the age varied between 7 and 63 years (mean 
age=27.33). MRIs were performed using a 2T scanner (Elscint 
Prestige®, Haifa, Israel), with T1 and T2 acquisitions in three or-
thogonal planes, including T1-weighted SE gadolinium-enhanced 
images. MRI acquisition parameters were: sagittal T1 spin echo, 
6 mm thick, 180° flip angle; repetition time (TR)=430 millisec-
onds, echo time (TE)=12 milliseconds, matrix 200×350, field of 
view (FOV)=25×25 cm; T2-weighted and proton density “fast spin 
echo” (FSE), 3 mm thick, 160° flip angle; TR=4.800 milliseconds, 
TE=108/18 milliseconds, matrix 256×256, FOV=22×22 cm; Axial 
T1-weighted spin echo (SE): TR=540 milliseconds, TE=28 milli-
seconds; axial T2-weighted fluid-attenuated inversion recovery 
(FLAIR) images TR=8.500 milliseconds and 2.000 or 100 millisec-
onds, and 2.200 milliseconds, TE=72 or 90 milliseconds, matrix of 
256×296 and FOV of 22×22 cm. T1-weighted SE gadolinium-en-
hanced images were obtained in three orthogonal planes.
All patients underwent surgical biopsy or tumor excision, 
according to clinical indication. The surgical specimens were 
processed for routine histopathology, and the classification 
of tumor type was performed following the World Health 
Organization (WHO) guidelines.
MRI files were evaluated by one neuroradiologist (FR). 
We analyzed the following variables: tumor location, signal 
on T1 and T2-weighted images, contrast enhancement, ede-
ma and association with other tumors in histological exami-
nation. The project was submitted to the Ethics Committee 
of our service, which approved the research protocol (pro-
cess nº 0722.0.146.000-10, approved Protocol nº 928/2010). 
Statistical analysis was performed with assessment of the 
statistics department of our service.
 RESULTS
Tables 1 and 2 summarize patient’s data. Patients ages 
ranged between 7 and 63 years (mean age=27.33 years; me-
dian=28.0; standard deviation=19.072). All patients were 
Table 1. Clinical data.
Patient Gender Age Symptom and clinical examination Time of symptom Recurrence (time) – follow-up
1 M 7 Generalized tonic-clonic seizures 3 years -
2 F 28 Seizures 13 years No – 3 yrs
3 F 31 Partial epilepsy, altered alertness and blurred vision 8 years No – 2 yrs
4 F 29 Seizures 2 weeks Yes (10 yrs) – 15 yrs
5 M 15 Seizures 9 years No – 6 yrs
6 M 7 Simple partial epilepsy and left parietal headache - -
7 M 63 Confusion, behavior changes, apathy and depression 1 month No – Death (1 mo)
8 M 16 Generalized tonic-clonic seizures 1 year No – 10 yrs
9 M 50 Confusion and syncope 3 months No – 9 yrs
M: masculine; F: feminine; yrs: years; mo: month.
Table 2. Imaging data.
Patient Location Side Imaging pattern*
Leptomenin-
geal contact Edema T1WI T2WI
Contrast 
enhancement Histopathology
1 Paracentral lobule Left Solid No No Hypointense Hyperintense Yes (homogeneous) Isolated PXA







3 Middle temporal gyrus Right
Solid-











5 Temporal pole Right Cystic No No Hypointense Hyperintense No PXA + cortical dysplasia
6 Parieto-occipital region Left
Solid-














8 Precentral and postcentral gyri Left
Solid-
cystic I Yes Mild Hypointense Hyperintense
Yes 
(heterogeneous) Isolated PXA
9 Frontal pole Left Solid-cystic I Yes Mild Hypointense Hyperintense Yes (minimal) Isolated PXA
PXA: pleomorphic xanthoastrocytoma.
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symptomatic at diagnosis, and the time of symptom presen-
tation was higher than three years in four of them. Seven pa-
tients presented history of epilepsy and the other two, mental 
confusion. Cortical location was observed in all nine cases. 
More than one lobe was affected in three patients. The pari-
etal lobe was the most affected ( five cases), followed by fron-
tal ( four) and temporal lobes (two). The lesion imaging was 
solid-cystic in six cases. Three imaging patterns were differ-
entiated: first, a cystic mass containing a mural nodule ( four 
cases); second, a predominantly solid mass that showed cys-
tic changes (one); and third, a mixed pattern (one). On T1-
weighted images, the solid component presented hypo– or 
isointense in all nine cases. While on T2-weighted images, 
the solid component presented isointense in four cases and 
hyperintense in seven. Leptomeningeal involvement was ob-
served in seven cases, and contrast enhancement in the solid 
component was observed in eight cases. Peritumoral edema 
was observed in four cases and its magnitude was marked 
(one) or mild (three). In three cases, PXA was associated with 
other cortical tumors in histopathology. Ganglioglioma was 
associated with PXA in two cases and with ependymoma and 
ganglioglioma in another one. Furthermore, cortical dyspla-
sia was associated with PXA in one case. Seven out of nine 
patients were followed up, one of whom had tumor recur-
rence (in the 10th postoperative year) and one died one month 
after surgery. The other five patients are still alive, well and 
clinically free from recurrence at different follow-up periods, 
ranging from two to ten years.
Statistical analysis showed that the presence of edema 
was associated with a symptom duration of less than one year 
prior to diagnosis (p<0.03) by Fisher’s exact test. Older age 
was associated with atypical clinical presentation (p<0.05) by 
Mann-Whitney test. No association was found between im-
aging patterns and clinical data or histological examination.
DISCUSSION
In 1979, Kepes et al.1 described for the first time a series 
of 12 young patients presenting with a distinctive form of as-
trocytoma. In all cases, the tumor was supratentorial and su-
perficial, with extensive leptomeningeal involvement and, 
despite pleomorphism and bizarre giant cells in the micro-
scopic picture, the prognosis was relatively favorable. Since 
this study, over 200 cases of PXA have been reported, most as 
single cases or small series13.
Typical clinical presentation includes a long history of 
epilepsy, especially in young patients, most commonly in 
the second decade of life9. Although 7 patients have present-
ed seizures in our study and 6 of them were younger than 
30 years, we had two patients with mental confusion as initial 
symptom, who were the oldest patients of our series (50 and 
63 years). In our sample, the atypical clinical presentation 
was significantly associated with older age (p<0.05) by Mann-
Whitney test. According to our knowledge, there are few re-
ports of elderly patients with PXA  in the literature; howev-
er, Ng et al.14 suggest that elderly patients with PXA may have 
a poor prognosis, considering age as an independent risk fac-
tor. In our sample, the oldest patient had a bad prognosis and 
died one month after surgery (Fig 1).
The most common single location is the temporal lobe, 
followed by parietal and occipital lobes. Moreover, out of 
the tumors that involve more than one lobe, the contiguous 
temporal lobe is the most affected9. In our study, temporal, 
parietal and frontal lobes were equally affected (two cases 
each  lobe), and, of the three tumors that involve more than 
one lobe, the parietal lobe was the most affected (three cases), 
followed by frontal lobe (two cases).
Despite its classic cortical location, PXA is rarely seen in 
the thalamus, cerebellum, spinal cord or within the eye15-19. 
Two cases of intraventricular PXA were recently described20,21.
On MRI, the solid component of PXA is predominantly 
isointense on T1-weighted images and mildly hyperintense 
on T2-weighted images, enhancing intensely after intrave-
nous contrast administration. Surrounding edema usually 
is minimal13. In our study, the solid component was hypo — 
or hyperintense in eight cases on T1-weighted images and 
iso — or hyperintense on T2-weighted images in eight cas-
es. Contrast enhancement was minimal (two), homoge-
neous (three) or heterogeneous (three). Peritumoral edema 
Fig 1. Male, 63 years old. (A) Contrast-enhanced axial T2-
weighted magnetic resonance (MR) image shows a frontal 
expansive solid-cystic lesion, with lobulated delineation. 
Cystic component shows hyperintensity. Contrast-enhanced 
axial T1-weighted MR image (B), coronal (C) and sagittal 
(D) shows enhancement in the solid component and at the 
periphery of the cystic component.
A B
C D
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was observed in four cases, being predominantly mild. Thus, 
these imaging findings corroborate a typical imaging pattern 
as described in the literature.
In the four cases in which edema was present in our sam-
ple, the duration of symptoms to diagnosis was less than or 
equal to one year, being significantly different from the other 
five cases, with greater time of evolution (p<0.03) by Fisher’s 
exact test. This finding may suggest that the presence of 
edema on PXA tumors may be associated with early tumor 
growth. Logically, the sample size does not allow generaliza-
tions, so further studies are essential.
In a histopathological study, PXA was associated with oth-
er tumors in three cases, two with ganglioglioma and another 
with ependymoma and ganglioglioma (Fig 2). Moreover, an-
other case of PXA showed association with cortical dysplasia 
(Fig 3). Furuta et al.22 proposed that PXA and ganglioglioma 
grow from a migration failure, resulting in an ectopic posi-
tion of neuronal and glial cells. That would explain the fact 
that PXA coexists in some cases with ganglioglioma or other 
cortical tumors. Furthermore, Lach et al.23 presented three 
cases of cortical dysplasia associated with PXA that suggest 
a possible preneoplastic role of cortical dysplasia in the sub-
sequent development of PXA.
In conclusion, although this sample comprises only nine 
patients, most reports of PXA have included only a single case 
or small series. MRI findings in this series corroborated a typ-
ical description of PXA. The observed imaging pattern of PXA 
was superficial location with leptomeningeal involvement, 
solid-cystic pattern and contrast enhancement in the solid 
component. On T1-weighted images, the solid component 
presented hypo — or isointense and, on T2-weighted images, 
it was iso — or hyperintense. In our sample, when edema was 
present, the duration of symptoms to diagnosis was less than 
Fig 2. Female, 29 years old. (A) Contrast-enhanced axial 
T1-weighted magnetic resonance (MR) image shows 
expansive cortical lesion in the left parietal lobe, with intense 
enhancement. (B) Axial T2-weighted MR image shows 
lesion predominantly isointense and moderate edema. 
Anatomopathology: Mixed tumor, with PXA, ganglioglioma and 
ependymoma components.
A B
Fig 3. Male, 15 years old. (A) Coronal T1-weighted magnetic 
resonance (MR) image shows a hypointense subcortical lesion 
and (B) Coronal T2-weighed MR image shows a hyperintense 
lesion. (C) Area of cortical dysplasia in right temporal lobe with 
incidental finding of a small pleomorphic xanthoastrocytoma, 
appearing as a well delimited, basophilic intracortical 
nodule. HE, X 10. (D) Pleomorphic xanthoastrocytoma is 
characterized by atypical rounded or fusiform tumor cells, 
some of which were multinucleated (center). HE, X 100. (E) 
Pleomorphic tumor cells with cytoplasmic positivity for GFAP, 
confirming their astrocytic lineage. Immunohistochemistry 
for GFAP, X 200. (F) Occasional cells displayed cytoplasmic 
xanthomatous change. Immunohistochemistry for vimentin, 
X 200. (G) Dysplastic area of cerebral cortex near the 
xanthoastrocytoma showing a binucleated neuron. HE, X 400. 
(H) Same area, gliosis of molecular layer of cerebral cortex 





or equal to one year. We should consider that the association 
of PXA with cortical dysplasia or other cortical tumors may 
occur, particularly with gangliogliomas, which tend to be the 
main differential diagnosis for MRI.
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